The antibiotic resistance survey: A preliminary report on the drug utilization evaluation study at the University Teaching Hospital, Charles University, Czech Republic

Pharmacoepidemiology and Drug Safety

Volumn 9, Issue 3, 2000, Pages 237-243

  Vlcek J ^a   Sleszarova P ^a   Pozlerova E ^a   Kotlar J ^a   Blaha V ^b   Mashburn, J ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Military Medical Agency   (Czech Republic)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antibiotic consumption; ATC DDD methodology; Drug microbial resistance; Drug utilization evaluation; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOPENICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; MACROLIDE; MEROPENEM; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CZECH REPUBLIC; DATA BASE; DRUG UTILIZATION; HUMAN; METHODOLOGY; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TEACHING HOSPITAL;

EID: 17444442560     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1557(200005/06)9:3<237::AID-PDS484>3.0.CO;2-M     Document Type: Article

References (21)

1. Seppälá H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythomycin resistance in group A streptococci in Finland. W Engl J Med 1997; 337(7): 441-446.
2. White Jr AC, Atmar RL, Wilson J, Cate TR, Stager ChE, Greenberg SB. Effects of prior authorisation for selected antimicrobials: Expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 1997; 25: 230-239.
3. Friedland IR, Funk E, Khoosal M, Klugman KP. Increased resistance to amikacin in a neonatal unit following intensive amikacin usage. Antimicrob Ag Chemother 1992; 36(8): 1596-1600.
4. Cailleax V, Mulin B, Capelier G, Julliot MC, Thouverez M, Talon D. Epidemiological study of variations in beta-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units. J Hosp Infect 1997; 37: 217-224.
5. Niederman MS. Is 'crop rotation' of antibiotics the solution to a 'resistant' problem in the ICU? Am J Respir Crit Care Med 1997; 156: 1029-1031.
6. Formsgaard A, Hoiby N, Friis HM, et al. Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units. Eur J Clin Microbiol Infect Dis 1995; 14(4): 275-281.
7. Low DE, Scheid WM. Strategies for stemming the tide of antimicrobial resistance. JAMA 1998; 279(5): 394-395.
8. Baršíć B, Beus I, Marton E, et al. Antibiotic resistance among Gram-negative nosocomial pathogens in the intensive care unit: results of the 6-year body-site monitoring. Clin Ther 1997; 19(4): 691-700.
9. Archibald L, Phillips L, Monnet D, McGowan Jr JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.
10. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996; 15(4): 281-285.
11. Mizushima Y, Li H, Yoshida I, Sassa K, Hamazaki T, Kobayashi M. Nosocomial septicemias due to methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in a university hospital over a 12-year period - the same intractable infections. Infection 1996; 24(3): 238-241.
12. Srikumar R, Xian-Zhi Li, Poole K. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J Bacteriol 1997; 179(24): 7875-7881.
13. WHO Colaborating Center for Drug Statistics Methodology. Antimicrobial Therapeutic Chemical (ATC) Classification Index (including Defined Daily Doses (DDDs) for plain substances). WHO: Oslo, 1994.
14. Vlček J, Pozlerová E, Lonská V, Kotláv̌ J. Analysis of the development of resistance of gram-negative rods to fluoroquinolones, amikacin, and third generation cephalosporines in relation to their use in a Faculty hospital in Hradec Králové. Remedia Klin Mikrobiol 1997; 1(6): 176-180.
15. Urbášková P, Hausnerová S, Lochmanová J. Standard method for establishing of MIC and MBC of bacterial isolates. Acta Hyg Epidemiolog Microbiol 1987; (Suppl): Prague, State Health Institute, (SZÚ).
16. Urbášková P. Resistance of bacteria to antibiotics, selected methods, (1st edn). Trios: Prague, 1998.
17. Cambau E, Gutmann L. Mechanisms of resistance to quinolones. Drugs 1993; 45(Suppl. 3): 15-23.
18. Cimino MA, Rotstein CM, Moser JE. Assessment of cost-effective antibiotic therapy in the management of infections in cancer patients. Ann Pharmacother 1994; 28: 105-111.
19. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 17(1): 20-24.
20. Dib C, Trias J, Jarlier V. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1995; 14(11): 979-986.
21. Blahová J, Králíková K, Krčméry V, Schäfer V, Toršová V. Transferable resistance to specific antibiotics in nosocomial strains of Pseudomonas aeruginosa from two teaching hospitals. J Chemother 1996; 8(6): 420-424.